NeuroSense Therapeutics Ltd. Description Of Expected Volatility Share Options Granted
NeuroSense Therapeutics Ltd. (NRSN) reported Description Of Expected Volatility Share Options Granted of 104.97% for the 6-month period ending 2023-06-30, per its 6-K filed 2023-08-16.
Discontinued › Notes
ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted · last filed 2023-08-16
| Period end | Description Of Expected Volatility Share Options Granted 6 month | Description Of Expected Volatility Share Options Granted 12 month |
|---|---|---|
| 2023-06-30 | 104.97% 6-K · filed 2023-08-16 | |
| 2021-12-31 | 90.61% 20-F · filed 2022-04-14 |